πŸ‡ΊπŸ‡Έ FDA
Patent

US 8288539

Dipeptidyl peptidase inhibitors

granted A61PA61P13/08A61P13/12

Quick answer

US patent 8288539 (Dipeptidyl peptidase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61P, A61P13/08, A61P13/12, A61P15/08, A61P15/16